PEB: Medicare loss hit FY25, but AUA guideline and APAC growth set stage for recovery

About this update from Pacific Edge Limited

FY25 revenue and test volumes declined due to Medicare non-coverage, but AUA guideline inclusion and APAC growth offer future upside. Cash burn remains high, with capital focused on evidence generation and product innovation. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pacific Edge Limited